Spherix (SPEX)
Spherix EBITDA Margin TTM: -413.3%
View SPEX EBITDA Margin TTM with YCharts Pro.
Access these YCharts Pro features:
Export any data you want
Save any chart as an image
Utilize advanced screener power
View 30 years of financial history
over 90 advanced calculations
Enjoy an advertising free experience
SPEX EBITDA Margin TTM Rankings
| Overall | 1st percentile | 3792 of 3851 |
| Sector | 8th percentile | 411 of 451 in Healthcare |
| Industry | 4th percentile | 24 of 25 in Medical Laboratories & Research |
SPEX EBITDA Margin TTM Range, Past 5 Years
| Minimum | -1467% | Mar 2008 |
| Maximum | -30.54% | Jun 2007 |
| Average | -496.1% |
About EBITDA Margin (TTM)
The EBITDA Margin is trailing twelve month earnings before interest, taxes, depreciation and amortization divided by trailing twelve month net sales.
Investors look at this measurement to get a closer approximation of performance of the business relative to sales before adjusting for the capital structure of the business (debt vs. equity financing).
Though many investors use EBITDA for this reason, some argue that the exclusion of depreciation expenses fails to capture the ongoing economics of a business since depreciation expenses are a good proxy for the replacement costs of property, plant and equipment, which must be paid in the future to continue business operations.
Learn More
You may also be interested in these SPEX related companies
SPEX News
Reminder: Spherix to Hold Business Update Conference Call April 11 at 1:00 p.m. Eastern Time
Apr 10, 11:05AM PR Newswire
Apr 10, 11:05AM PR Newswire
RT @idrinkchai $SPEX might holy grail here on intraday, what do you mean by that
about 86 days ago by allars
about 86 days ago by allars
Spherix (SPEX) Rips After Positive SPX-106T Data on Atherosclerotic Plaque Reduction
Mar 07, 10:19AM Street Insider
Mar 07, 10:19AM Street Insider
SPX-106T Arrests Development of Atherosclerotic Plaques in Mouse Model of Cardiovascular Disease
Mar 07, 9:15AM PR Newswire
Mar 07, 9:15AM PR Newswire
Spherix to Present at the LHA Life Sciences & Medical Technologies Virtual Conference on February 16
Feb 10, 10:42AM PR Newswire
Feb 10, 10:42AM PR Newswire
Spherix $SPEX Shares Halted on Breaker Down 22% Following $1.15M Offering
about 120 days ago by Street_Insider
about 120 days ago by Street_Insider
Spherix (SPEX) Shares Halted on Breaker Down 22% Following $1.15M Offering
Feb 02, 2:48PM Street Insider
Feb 02, 2:48PM Street Insider
Shares of Spherix Inc. (SPEX) Trade Up 40% on SPX-106 28-day Rat Toxicology Study Results
Jan 11, 11:51AM Street Insider
Jan 11, 11:51AM Street Insider
Spherix Announces Successful Completion of Important Toxicology Study of SPX-106
Jan 11, 9:47AM PR Newswire
Jan 11, 9:47AM PR Newswire
Spherix Issues Reminder of Business Update Conference Call Set for Today at Noon Eastern Time
Nov 16, 10:03AM PR Newswire
Nov 16, 10:03AM PR Newswire
$SPEX http://stks.co/9tx Showed they could reduce cholesterol levels in mice
about 266 days ago by Tr8r_x
about 266 days ago by Tr8r_x
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| SPEX | 0.75 | -0.03 | -3.85% | 3.12M |
| SPCHB | 1.716 | +0.03 | +1.54% | 3.054M |
| SPCHA | 1.22 | -0.15 | -10.95% | 15.14M |
| SPBC | 12.85 | +0.00 | +0.00% | 22.23M |
| SPB | 33.15 | -1.37 | -3.97% | 1.787B |
| SPAR | 4.21 | -0.29 | -6.44% | 151.29M |
| SPAN | 17.51 | +0.01 | +0.06% | 51.10M |
| SPAB | 1.07 | +0.04 | +3.88% | |
| YGE | 2.71 | +0.11 | +4.23% | 378.53M |
| YELP | 15.59 | -1.12 | -6.70% |
